Sanofi to cut US price of its most-prescribed insulin by 78%
17 Mar 2023 //
REUTERS
Sanofi`s Biologic APIDRA (Insulin Glulisine) Receives Approval in the U.S.
30 Nov 2022 //
FDA
Sanofi talks up personalized diabetes care in patient-centric awareness push
10 Jun 2019 //
FIERCE PHARMA
FDA Requires New Labeling on Insulin Pens to Ward off Spread of Infections
03 Mar 2015 //
FIERCE DRUG DELIVERY
It`s Put Up or Shut Up Time for Sanofi and Mannkind as Afrezza Hits the Market
03 Feb 2015 //
FIERCE PHARMA